Fundraising Fox
Sitryx
Founded 2018 · 49 employees on LinkedIn · 5 known investors
Find your way into Sitryx
Sign up to see every warm intro you have to Sitryx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sitryx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.
Investors · 5
How we know: Longwood Fund's portfolio page · the company's own site · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the company's own site · Oxford Science Enterprises's portfolio page · Not right? Tell us
How we know: Sofinnova Partners's portfolio page · the company's own site · open dataset · 5k.vc investor directory · Not right? Tell us
Founder mafia
3 people who came through Sitryx went on to found or lead other companies.
Frequently asked questions
- What does Sitryx do?
- Sitryx is a biotechnology company, founded in 2018, developing therapeutics with a focus on immunometabolism. It has entered a global licensing and research collaboration with Eli Lilly and Company.
- Who are Sitryx's investors?
- Sitryx's investors include Longwood Fund, Oxford Science Enterprises, Sofinnova Partners, SV Health Investors, Dementia Discovery Fund.